InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Baum Charles M, 董事长兼首席执行官. Officer active across 2 companies, notably Mirati Therapeutics, Inc.. In total, 18 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €690k. Activity tracked since 18 June 2021. The latest transaction was disclosed on 17 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Baum Charles M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
78,600 股Common StockSEC:0001415889-25-001085:0
19,650 股0Common StockSEC:0000950170-24-074864:0
123,389 股Common StockSEC:0001140361-24-003528:0
94,057 股Common StockSEC:0001140361-24-003528:1
20,425 股Common StockSEC:0001140361-24-003528:2
20,425 股@ US$58.7516.5% 占其流量Common StockSEC:0001628280-24-000277:0
54,054 股@ US$37.0027.7% 占其流量Common StockSEC:0001628280-23-028884:0
19,650 股0Common StockSEC:0000950170-23-028605:0
4,444 股0Common StockSEC:0001214659-23-001049:0
3,648 股@ US$46.602.5% 占其流量Common StockSEC:0001214659-23-000290:0
53,618 股0Common StockSEC:0001214659-22-015200:0
69,256 股@ US$17.4117.7% 占其流量Common StockSEC:0001214659-22-014229:0
39,300 股0Common StockSEC:0001209191-22-037669:0
25,543 股0Common StockSEC:0001214659-22-000856:0
4,045 股@ US$147.739.8% 占其流量Common StockSEC:0001214659-22-000419:0
7,430 股0Common StockSEC:0001214659-21-013378:0
47,204 股@ US$8.496.6% 占其流量Common StockSEC:0001214659-21-012712:0
40,000 股@ US$8.495.3% 占其流量Common StockSEC:0001214659-21-006762:0
18 条申报中的 18 条
About Baum Charles M
BAUM CHARLES M is Président-Directeur Général. He has 18 filings in total. Across the 18 sampled filings, sales amount to EUR 689899, over the period from 2021-06-21 to 2025-01-08, and the main filings concern Mirati Therapeutics, Inc.
